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Abstract
The similarities of two major peanut allergens, Ara h 2 and Ara h 6, in molecular size, amino acid
sequence, and structure have made it difficult to obtain natural Ara h 6 free of Ara h 2. The
objectives of this study were to purify natural Ara h 6 that is essentially free of Ara h 2 and to
compare its IgE reactivity and potency in histamine release assays to Ara h 2. SDS-PAGE of the
highly purified allergen (<0.01% Ara h 2) revealed a single 14.5kD band and the identity of Ara h
6 was confirmed by LC-MS/MS. Ara h 6 showed a higher seroprevalence in chimeric-IgE ELISA
(n=54), but a weaker biological activity in basophil histamine release assays than Ara h 2. Purified
Ara h 6 will be useful for diagnostic IgE antibody assays, as well as molecular and cellular studies
to investigate the immunological mechanisms of peanut allergy.
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Introduction
Peanut allergy is an important food allergy in the United States that affects 1.4 % of children
and 0.6% of adults.(1, 2) In the United Kingdom, approximately 1.8% of children have an
allergy to peanut.(3, 4) While most children outgrow food allergies to milk, egg, or wheat;
allergy to peanut is more persistent and often continues into adulthood.(5) Minute amounts
of peanut, as little as 0.4 g, are enough to elicit milder allergic symptoms that include rashes,
angioedema, and gastrointestinal symptoms.(5, 6) However, peanut is also one of the main
triggers of severe anaphylactic reactions that can be fatal.(7)
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Currently, 12 peanut allergens have been documented by the WHO/International Union of
Immunological Societies (IUIS) Allergen Nomenclature committee.(8) Ara h 1 and Ara h 2
have been well-studied and are recognized as major allergens. Ara h 2 has a higher
predictive value for diagnosis of clinical peanut allergy than Ara h 1, Ara h 3, Ara h 8 and
Ara h 9.(9) Ara h 2 is also more potent than Ara h 1 or Ara h 3 in histamine release assays
and skin prick tests.(10–12)
Another peanut allergen, Ara h 6, has recently emerged as an important allergen which,
together with Ara h 2, has been associated with clinical peanut allergy.(13) Ara h 6 has
approximately the same seroprevalence as Ara h 2 and thus is considered a major peanut
allergen.(13, 14) Ara h 6 and Ara h 2 are of similar molecular size – Ara h 2 is 17–19 kDa and
Ara h 6 is 14.5 kDa. Both allergens are 2S albumins that are heat-stable, immunogenic and
resistant to digestion in the gut.(15–17) The nucleotide (or amino acid) sequences of Ara h
2.0101 and Ara h 6.0101 are 50% identical and 58% similar (EMBOSS Needle alignment).
The structure of the protease-resistant core of Ara h 6 has previously been determined by
NMR and the folds of this allergenic core were found to be virtually identical to that of Ara
h 2.(15) The 3-dimensional folds determine the IgE epitopes which are lost upon
unfolding.(18) More recently, the structure of Ara h 2 was determined by X-ray
crystallography and molecular modeling studies predict that half of the residues on the
surfaces of both proteins are conserved.(19) These factors contribute to the difficulty in
obtaining purified natural Ara h 6 (nAra h 6) that is free of Ara h 2. Ara h 7, the third peanut
allergen of the 2S albumin family also shows sequence homology to Ara h 2 and Ara h 6.(20)
However, attempts to identify natural Ara h 7 protein in peanut extracts have failed.
Recently, Schmidt et al found low abundance of natural Ara h 7.0201 and Ara h 7.0202 in
peanut extracts after enrichment of the low molecular mass peanut proteins.(21)
Highly purified allergens are important for allergen standardization.(22, 23) There is
extensive variability in allergen composition and potency between different commercially
available peanut extracts, including those used for skin prick testing that could lead to
misdiagnosis.(24, 25) ‘Component-resolved’ or molecular diagnostics is based on measuring
IgE antibodies to multiple individual allergens rather than to heterogeneous extracts. The use
of molecular diagnostics tends to lower false-positive IgE antibody results caused by
interaction with profilins and cross-reactive carbohydrate determinants that are present in
diverse plant-based food.(26–29) Some birch pollen-allergic patients were found to be cross-
sensitized to peanut through cross-reactivity between Bet v 1 and Ara h 8, which are
homologous proteins that belong to the PR-10 family.(30) Moreover, pea-allergic patients
who later developed peanut allergy recognized only Ara h 1, but not Ara h 2 or Ara h 3.(31)
Vicilin homologues in pea and peanut (Ara h 1) are the molecular basis for this cross-
reactivity. Most peanut-allergic patients that react to Ara h 2 also have IgE against Ara h 6;
however, a recent case study reported that Ara h 6 caused severe reactions to peanut in the
absence of sensitization to Ara h 2.(32) Thus, it is important to have pure, single-component
peanut allergens for accurate diagnosis of peanut allergy.
Our objective in this study was to obtain purified nAra h 6 that is essentially free of Ara h 2
and to compare its IgE reactivity and potency in histamine release assays to Ara h 2.
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Materials and Methods
Purified Natural Ara h 6
Peanut flour was extracted into Phosphate buffered saline, pH 7.4 (PBS) containing 1 M
sodium chloride for 2 hours at 60 °C. The mixture was centrifuged at 13,500 x g for 25
minutes and the supernatant was sterile filtered. Ammonium sulfate precipitation was used
to remove contaminating Ara h 1. The 70–100% pellet containing Ara h 6 and Ara h 2 was
redissolved in PBS and passed over a 1C4 monoclonal antibody column to remove the
contaminating Ara h 2. Size exclusion chromatography (HiPrep 16/60 Sephacryl S-100 HR,
GE Life Sciences, Uppsala, Sweden) was used as a final polishing step. The identity of
purified nAra h 6 was confirmed by liquid chromatography-tandem mass spectrometry (LC-
MS/MS) and its purity was analyzed by SDS-PAGE and silver staining. The concentration
of the purified protein was determined by the Advanced Protein Assay (Cytoskeleton,
Denver, CO.) and the Ara h 2 content was measured using a two-site antibody ELISA with
monoclonal antibody 1C4 as the capture antibody and rabbit-polyclonal antibody anti-Ara h
2 for detection.(33) Ara h 6 was measured by ELISA using capture monoclonal antibody 3B8
and detection antibody 3E12. Another nAra h 6 preparation available from TNO Quality of
Life, Zeist, The Netherlands (T-Ara h 6) was tested for comparison.
Sera
Sera for the immunoblotting, chimeric-IgE ELISA and cross-inhibition ELISA were
obtained from Bioreclamation, Inc. (East Meadow, NY) (n=24), which operates in full
compliance with the Food and Drug Administration guidelines, the Department of Allergy
and Clinical Immunology at Johns Hopkins University (n=25) and kindly provided by Dr.
Peter Heymann, University of Virginia (n=8). Sera for the Basophil Histamine Release
Assay were provided by the Department of Allergy, Asthma and Clinical Immunology at the
University of Colorado (n=20). All donors signed informed consent and, for minors, assent.
Sera were collected with approval from the respective institutions’ Human Investigation
Committees.
Immunoblotting
IgE reactivity of purified nAra h 6 was compared to natural Ara h 2 (nAra h 2), peanut
extract and T-Ara h 6 by immunoblot using pooled sera from six peanut-allergic patients (≥
100 kU/L by chimeric-IgE ELISA, PWH6, BR13, BR21, BR22, BR23, BR24). Proteins
loaded at 0.5 mg/ml and separated by SDS-PAGE under non-reducing conditions
(Homogenous 20%, GE Lifesciences, Uppsala, Sweden) were transferred to a
polyvinylidene difluoride (PVDF) membrane (Bio-Rad Laboratories, Hercules, CA) by
electroblotting. The membrane was blocked with 5% non-fat dry milk in 25 mM Tris, 150
mM NaCl, pH 7.4, 0.05% Tween-20 for 16 hours at 4 °C and then incubated with the pooled
sera at a 1:2 dilution in blocking buffer for 2 hours at room temperature. Bound IgE was
detected with peroxidase-labeled goat anti-human IgE (Kirkegaard & Perry Laboratories,
Inc, Gaithersburg, MD) followed by ECL™ Western Blotting Analysis System (GE
Lifesciences, Uppsala, Sweden), which produced a detectable chemiluminescent signal.
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Chimeric-IgE ELISA
IgE antibody binding to nAra h 6 was compared to IgE binding to T-Ara h 6 and nAra h 2
by a modified chimeric-IgE ELISA as described previously.(34–36) Briefly, microtiter plates
coated to saturation with one allergen at 0.5 Vg/well were incubated with sera from peanut-
allergic patients (ImmunoCAP values ranged from 0.45 to > 100 kUA/L; average 15.2 ±
21.4 kUA/L, n = 54). Bound IgE antibody was detected using biotinylated goat anti-human
IgE (Kierkegaard and Perry, Gaithersburg, MD) followed by streptavidin-peroxidase. The
intensity of the color developed by ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic
acid)) was measured at 405 nm. A chimeric anti-Der p 2 antibody, 2B12-IgE, was used to
establish a standard curve from 0.4 – 115 U/ml IgE to quantify the bound specific IgE as
previously reported.(36) Ara h 6 and Ara h 2-specific IgE for each serum sample were
extrapolated from the linear portion of the 2B12-IgE curve. Levels of specific IgE antibody
reactive with nAra h 6 and nAra h 2 or T-Ara h 6 were plotted and modeled using linear
regression. Pearson correlations were used to analyze the relationship between specific IgE
to nAra h 6 and nAra h 2 or T-Ara h 6 in peanut allergic patients sera.
Cross-inhibition ELISA
The chimeric-IgE ELISA was modified for cross-inhibition assays. Microtiter plates were
saturated with nAra h 6 or nAra h 2 at 0.5 Vg/well for 16 hours at 4 °C.(34) A serum pool of
the same sera used in the immunoblot was incubated with increasing concentrations of the
inhibitor (either nAra h 6 or nAra h 2) for one hour prior to performing the assays. Protein
concentration of the inhibiting allergen was increased in 10-fold increments from 10 to
10,000 ng/ml. The pooled sera with or without the inhibitor were added to their respective
wells and incubated at room temperature for one hour. Bound IgE was detected as described
for the Chimeric-IgE ELISA. The percent inhibition was calculated based on the optical
density at 405 nm. 0% inhibition was assumed for the wells that had no inhibitor.
Basophil Histamine Release Assay
The stripped basophil histamine release assay was performed as previously described.(37)
Briefly, basophil cells were stripped of membrane-bound IgE and sensitized with each
serum from peanut-allergic patients (Ara h 6 specific IgE values ranged from 5 to 480
kUA/L; average 87.8 ± 125 kUA/L, n=20). The cells were then stimulated with increasing
concentrations of allergen and histamine release was measured by fluorometric analysis.
Histamine release was expressed as a percentage of the total amount of histamine in the cells
determined after lysis of the cells with perchloric acid (100% release). The EC50 was the
allergen concentration required to stimulate 50% of the maximum release. Histamine release
dose response curves for nAra h 6 and nAra h 2 were generated for concentrations between
0.001 and 1000 ng/ml.
Results
Protein Characterization
Purified nAra h 6 (Lane 4) and T-Ara h 6 (Lane 5) migrated as single bands on silver-stained
SDS-PAGE at the predicted molecular weight of 14.5 kDa (Figure 1A). Ara h 6 content was
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1.05 mg/ml while the concentration of Ara h 2 was less than 0.1 Vg/ml (0.01 %) as
measured by two-site antibody ELISA. The results of LC-MS/MS confirmed the identity of
the purified allergen as Ara h 6.0101 with 74.5% sequence coverage (Figure 2).
IgE Binding Analysis
Immunoblotting demonstrated strong IgE reactivity to nAra h 2 (Lanes 2 and 3), nAra h 6
(Lanes 4 and 5) and peanut extract (Lane 1, Figure 1B). The major allergens, Ara h 1 (63
kDa), Ara h 2 (18–20 kDa), and Ara h 6 can be seen as major bands in the peanut extract.
Ara h 2 was not detected in the purified nAra h 6 preparation.
More sera showed IgE binding to nAra h 6 than to nAra h 2 (45 vs. 39) using a chimeric
IgE-ELISA; however, the levels of Ara h 2-specific IgE were on average 13 % higher than
the levels of Ara h 6-specific IgE. Twenty-five of these patients had higher levels of
specific-IgE to one allergen but not to the other (Table 1). For example, patient BR1 had
four-fold higher Ara h 2- than Ara h 6-specific IgE while patient BH25 had five-fold higher
Ara h 6- than Ara h 2-specific IgE (Table 1). There was a strong quantitative correlation
between the levels of specific IgE to nAra h 6 and specific IgE to nAra h 2 (r = 0.91, n = 54,
p < 0.001; Figure 3A). The levels of Ara h 6-specific IgE binding to purified nAra h 6
correlated well with the same Ara h 6-specific IgE binding to T-Ara h 6 (r = 0.98, n = 39, p
< 0.001; Figure 3B). On average, the IgE binding to the purified nAra h 6 material was 46%
higher than that observed interacting with T-Ara h 6.
Results obtained in the cross-inhibition assay indicate that nAra h 2 inhibited IgE-allergen
binding more effectively than nAra h 6. At 70 ng/ml, Ara h 2 inhibited 50% of IgE-Ara h 2
and IgE-Ara h 6 interactions (Figure 4). However, 600 ng/ml and 5000 ng/ml of Ara h 6
were required to inhibit 50% of IgE binding to Ara h 6 and Ara h 2, respectively.
Biological Activity
Natural Ara h 6 showed less biological activity than nAra h 2 in the basophil histamine
release assay (Fig.5). At a concentration of 0.1 Vg/ml, Ara h 2 stimulated 50% of the
maximum histamine release, while 1 Vg/ml of Ara h 6 was required to achieve 50% of
maximum histamine release. In general, histamine release was 10% lower for nAra h 6 than
nAra h 2 at the same allergen concentration. The dose-response curve of histamine release
by nAra h 6 was shifted to the right of the dose response curve for nAra h 2 (Figure 5). On
average, histamine release began to plateau at 0.001 μg/ml of Ara h 2 and continued an
upward trend even to a concentration of 1 Vg/ml of Ara h 6.
Discussion
Peanut allergy is on the rise as evidenced by a 1% increase in just over an 11 year period
(1997–2008) in the US.(2) Traces of peanut can be found in many processed foods and this
poses a danger to peanut allergic patients as miniscule amounts can trigger an allergic
reaction.(6) Previous studies have demonstrated significant variability in the protein content
and allergenicity of commercially available peanut extracts.(38) There is a critical need for
ultra-pure allergens to clarify research results and improve the accuracy of diagnostic tests in
an attempt to better understand the mechanisms associated with the induction of allergic
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diseases. Analysis of single components allows more effective dissection of cross-reactivity
among structurally similar allergens and aids in identifying the cross-reactive allergen from
the allergen that initially elicited the sensitization. For food allergy studies in particular,
molecular diagnostics more effectively reveal patterns of sensitization and cross-reactivity
among allergenic homologues across food groups.(39)
Ara h 2 has been extensively studied and established as a major allergen, while Ara h 6 has
only recently gained interest in peanut allergy research. Ara h 2 and Ara h 6 belong to the
2S-albumin family that are characterized by having a stable core formed by four disulfide
bridges, which makes these proteins resistant to high-temperature processing and proteolytic
digestion.(16, 40) The stability of these proteins and their resistance to digestive enzymes in
the gut has been identified as major factors contributing to their allergenicity.(15, 41) The
sequence and structural similarity between Ara h 6 and Ara h 2 has made it difficult to
produce nAra h 6 that is free of nAra h 2.(19) Recombinant Ara h 6 has been produced but
conformational differences between the natural and recombinant forms have yielded
recombinant Ara h 6 with low IgE reactivity.(20) More recently, a recombinant Ara h 6
produced in Pichia pastoris has shown improved biological potency similar to that of nAra h
6.(42)
Highly purified nAra h 6, has analytically been shown to be free of Ara h 2. Similar to
natural Ara h 2, natural Ara h 7 also shares sequence similarity with Ara h 6 and thus may
have the potential to co-purify with the Ara h 6. However, natural Ara h 7 has a very low
abundance in peanut extracts, which greatly minimizes the risk of contamination.(21)
Purified natural Ara h 6 displayed its own unique immunological activity patterns. While a
good correlation was shown between the relative levels of Ara h 2-specific IgE and Ara h 6-
specific IgE, sera from twenty-five individuals reacted more strongly to one allergen than
the other, as has been reported in previous studies.(16, 32, 43) Interestingly, only eight out of
the twenty-five tested sera had higher Ara h 2-specific IgE even though Ara h 2 is the
predominantly-recognized allergen by peanut allergic patients.(13)
In our cross-inhibition analyses, Ara h 2 inhibited Ara h 6-specific-IgE binding more
effectively than Ara h 6 inhibited Ara h 2-specific IgE binding, and has been reported
previously.(16) The inhibitory effect of Ara h 2 may be due to its unique IgE-binding
epitopes that are not present in Ara h 6 while Ara h 6 contains IgE-binding epitopes that are
also present on Ara h 2.(44) However, we did not achieve complete inhibition of Ara h 6-IgE
binding by Ara h 2 even at 10 Vg/ml, which suggests that Ara h 6 could have unique IgE-
binding epitope(s). This is supportive of the report by Lehmann et al. who performed an
enzyme allergosorbent test and found that maximal inhibition by recombinant Ara h 2 and
recombinant Ara h 6 was only 70% and 60%, respectively.(15, 45)
Ara h 2 consistently induced higher levels of histamine release than Ara h 6 in basophil
studies. In general, a 10-fold lower concentration of Ara h 2 than Ara h 6 was required to
induce the same amount of histamine release. Similarly, Ara h 2 was recently found to be
more potent than Ara h 6 using the RBL SX-38 cells assay although the magnitude of the
difference was less than we report here with the stripped basophil assay.(46) Ara h 2 also
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elicited a higher magnitude of mediator release at lower concentrations than Ara h 6.(15)
However, as the allergen concentration increased, Ara h 6 induced the release of higher
percentages of β-Hexosaminidase than Ara h 2.(47)
While most published data suggest that Ara h 2 is more potent than Ara h 6, there are
exceptions. Ara h 6 had a higher seroprevalence (83.3%) than Ara h 2 (72.2%) in our study
that involved the testing of 54 sera from peanut-allergic patients. In another study, Ara h 6
was shown to produce a stronger Th2 response than Ara h 2 in peripheral blood
mononuclear cells of peanut-allergic children.(48) The depletion of Ara h 2 or Ara h 6 alone
from crude peanut extract did not cause a significant reduction in the maximal net level of
mediator release from SBX-38 cells, but the removal of both allergens decreased effector
activity by approximately 20 %.(49) Previously, Ara h 2 and 6 together were shown to be
responsible for over 60% of the effector activity.(50) Furthermore, in vivo studies using
murine models showed that desensitization with Ara h 2/6 mixture and crude peanut extract
produced comparable results.(51, 52)
Peanut allergy associated with sensitization to storage proteins (Ara h1, Ara h 2, Ara h 3,
Ara h 6 and Ara h 7) presents the most serious form of peanut allergy.(53) While Ara h 1
and Ara h 3 are the most abundant storage proteins in peanut (11–31% and 38–76% of
protein content in peanut extracts respectively), patients with peanut allergy recognize
predominantly Ara h 2 and Ara h 6.(13, 14, 54) Molecular diagnostics have shown that the
combined results of IgE reactivity to the two storage proteins Ara h 2 and Ara h 6 yielded
the highest diagnostic sensitivity and specificity for detecting clinically evident peanut
allergy.(13) By themselves, Ara h 2 and Ara h 6 had high diagnostic sensitivity and
specificity compared to Ara h 1 and Ara h 3, but together, the two 2S albumin proteins were
able to predict peanut allergy with 98% sensitivity and 85% specificity at a predictive
threshold of 0.1 kU/L. The addition of specific IgE tests for other storage proteins such as
Ara h 6 or Ara h1 and Ara h 3, will increase specificity and sensitivity of molecular
diagnosis, as not all patients with clinical peanut allergy show sensitization to Ara h 2 (32,
53, 55). Thus, purified nAra h 6 should be considered an important diagnostic reagent for
both in vitro and in vivo assays, that, together with nAra h 2 will improve diagnostic,
immunologic, and biologic assays used in the investigation of peanut allergy, T-cell studies
and mouse models of asthma.
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Abbreviations Used
nAra h 6 natural Ara h 6
nAra h 2 natural Ara h 2
T-Ara h 6 TNO-produced Ara h 6 used as a reference
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SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis
LC-MS/MS Liquid chromatography-tandem mass spectrometry
ELISA Enzyme-linked immunosorbent assay
WHO World Health Organization
PR-10 Pathogenesis-related class 10 protein
PVDF Polyvinylidene difluoride
ABTS 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
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Figure 1.
Silver-stain and immunoblot of nAra h 2, nAra h 6, and peanut extract using pooled sera
from six peanut-allergic patients. A) Silver-stained gel; B) Proteins transferred onto a PVDF
membrane were probed with sera, and bound IgE was detected with a peroxidase-labeled
goat anti-human IgE. Lane M: Marker, Lane 1: Peanut extract, Lane 2 and 3: nAra h 2, Lane
4: nAra h 6 and Lane 5: T-Ara h 6.
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Figure 2.
Sequence coverage of purified nAra h 6 with Ara h 6.0101. Underlined red letters indicate
identical amino acids between the purified allergen and the published sequence.
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Figure 3.
Correlation between IgE-binding to purified nAra h 6 and purified nAra h 2 (A) and between
purified nAra h 6 and T-Ara h 6 (B). Allergen coated onto microtiter plates was incubated
with sera from peanut-allergic patients and bound IgE was detected by biotin-labeled goat
anti-human IgE followed by streptavidin-peroxidase. The intensity of the color development
of ABTS was measured at 405 nm.
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Figure 4.
Specific IgE cross-inhibition assay with increasing inhibitor allergen concentrations of Ara h
2 and 6. A) Percent inhibition of Ara h 6-specific IgE binding activity. B) Percent inhibition
of Ara h 2-specific IgE binding activity.
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Figure 5.
Average basophil histamine release by nAra h 2 and nAra h 6 (n = 20) using increasing
concentrations of allergen.
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Table 1
Ara h 2 and Ara h 6 specific IgE concentrations of sera of peanut allergic patients that were positive to at least
one of the two allergens as measured by Chimeric ELISA. Sera with a ratio of Ara h 2-specific IgE: Ara h 6-
specific IgE > 2 or <0.5 are highlighted in bold.
INDOOR ID# Ara h 2 (kUA/L) nAra h 6 (kUA/L)
BH1 8.96 10.9
BH2 223 109
BH3 9.59 7.02
BH4 3.61 8.7
BH5 8.43 20
BH6 345 383
BH7 499 814
BH8 1.03 10.8
BH9 40.1 7.9
BH10 0.56 0.89
BH11 <0.4 0.7
BH12 58.3 79.5
BH13 108 187
BH14 1.89 3.62
BH15 0.93 0.92
BH16 <0.4 1.71
BH17 13.6 10.1
BH18 1.05 13.3
BH19 7.32 17.4
BH21 0.35 0.6
BH22 1.47 1.23
BH23 14.2 28.9
BH24 4.83 2.06
BH25 58.3 326
BR1 270 61.7
BR2 38.4 89.2
BR4 <0.4 0.7
BR5 20.2 4.17
BR6 3.67 3.51
BR8 0.89 4.89
BR11 <0.4 0.6
BR12 0.4 <0.4
BR13 568 520
BR14 0 0.8
BR16 2.63 3.07
BR17 58.4 6.71
BR18 96.8 36.1
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INDOOR ID# Ara h 2 (kUA/L) nAra h 6 (kUA/L)
BR21 208 145
BR22 140 151
BR23 299 164
BR24 269 93.1
PWH1 <0.4 0.57
PWH3 0.8 5.31
PWH4 0.33 0.66
PWH5 <0.4 0.71
PWH6 1657 1113
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